Cannara Biotech Inc. (V:LOVE)
Business Focus: Medical Farming
Feb 08, 2024 07:37 am ET
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans
Cannara Biotech Inc CFO Nicholas Sosiak
joined Steve Darling from Proactive to provided valuable insights into
the company's success in the cannabis industry.
Jan 30, 2024 07:30 am ET
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023
Jan 30, 2024 07:30 am ET
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023
Jan 08, 2024 07:30 am ET
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
MONTREAL, Jan. 8, 2024 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced it has retained Independent Trading Group ("ITG") to provide market making services in accordance with TSX Venture Exchange policies.
Jan 08, 2024 07:30 am ET
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
MONTREAL, Jan. 8, 2024 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced it has retained Independent Trading Group ("ITG") to provide market making services in accordance with TSX Venture Exchange policies.
Dec 13, 2023 09:30 am ET
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
MONTREAL, Dec. 13, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host the Company's annual general meeting of shareholders on January 25th, 2024 at 11:00 am EST. The meeting will be held by way of a live webcast and teleconference (per the instructions below).
Dec 13, 2023 09:30 am ET
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
MONTREAL, Dec. 13, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host the Company's annual general meeting of shareholders on January 25th, 2024 at 11:00 am EST. The meeting will be held by way of a live webcast and teleconference (per the instructions below).
Dec 11, 2023 07:30 am ET
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
MONTREAL, Dec. 11, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Thursday, December 14th, 2023, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have an oppo
Dec 11, 2023 07:30 am ET
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
MONTREAL, Dec. 11, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Thursday, December 14th, 2023, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have
Dec 07, 2023 07:30 am ET
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022
Dec 07, 2023 07:30 am ET
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022
Jul 27, 2023 08:00 am ET
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
Three- and nine-month net revenue were $15.9 million and $39.3 million, a 57% and 63% increase compared to the same periods of prior year
Jul 27, 2023 08:00 am ET
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
Three- and nine-month net revenue were $15.9 million and $39.3 million, a 57% and 63% increase compared to the same periods of prior year
May 23, 2023 08:00 am ET
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings.
May 11, 2023 08:00 am ET
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
MONTREAL, May 11, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its upcoming participation at Canaccord Genuity's 7th annual global cannabis conference. This one-day event will feature company presentations and one-on-one meetings with senior management teams representing the most reputable and recognizable names in the thriving cann
May 11, 2023 08:00 am ET
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
MONTREAL, May 11, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its upcoming participation at Canaccord Genuity's 7th annual global cannabis conference. This one-day event will feature company presentations and one-on-one meetings with senior management teams representing the most reputable and recognizable names in the thrivi
May 04, 2023 08:00 am ET
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
MONTREAL, May 4, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that they have raised an additional $10 million of credit facilities from its lead bank, BMO Commercial Banking via a $5 million increase in its term loan facility and a $5 million increase in its revolving line of credit. Under the terms of the initial agreement that was
May 04, 2023 08:00 am ET
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
MONTREAL, May 4, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that they have raised an additional $10 million of credit facilities from its lead bank, BMO Commercial Banking via a $5 million increase in its term loan facility and a $5 million increase in its revolving line of credit. Under the terms of the initial agreement t
Apr 25, 2023 08:00 am ET
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
MONTREAL, April 25, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, May 4th, 2023, at 2:00 PM ET.
Apr 25, 2023 08:00 am ET
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
MONTREAL, April 25, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, May 4th, 2023, at 2:00 PM ET.
Apr 24, 2023 08:00 am ET
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
Six-month net revenues of $23.4 million, a 67% increase compared to first half 2022
Apr 24, 2023 08:00 am ET
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
Six-month net revenues of $23.4 million, a 67% increase compared to first half 2022
Feb 28, 2023 02:45 pm ET
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan
MONTREAL, Feb. 28, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that it has entered into an automatic share purchase plan ("ASPP") with Raymond James Ltd. ("Raymond James"), acting as Cannara's broker, in order to facilitate repurchases of the Company's common shares ("Common Shares") under its previously announced normal course issuer bid
Feb 10, 2023 07:00 am ET
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE
MONTREAL, Feb. 10, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that further to its news release dated January 11, 2023, the Company held its annual shareholder meeting on January 25, 2023 (the "Meeting").
Feb 10, 2023 07:00 am ET
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE
MONTREAL, Feb. 10, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that further to its news release dated January 11, 2023, the Company held its annual shareholder meeting on January 25, 2023 (the "Meeting").
Jan 23, 2023 07:00 am ET
Cannara Biotech Inc. Reports Q1 2023 Financial Results
Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022
Jan 23, 2023 07:00 am ET
Cannara Biotech Inc. Reports Q1 2023 Financial Results
Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022
Jan 12, 2023 08:00 am ET
Cannara Announces Proposed Share Consolidation
MONTREAL, Jan. 12, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announces details of its proposal to consolidate all of the issued and outstanding common shares of the Company on the basis of ten (10) pre-consolidation common shares for every one (1) post-consolidation common shares, subject to the approval of shareholders at the upcoming meeting of shareholders to take pla
Jan 12, 2023 08:00 am ET
Cannara Announces Proposed Share Consolidation
MONTREAL, Jan. 12, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announces details of its proposal to consolidate all of the issued and outstanding common shares of the Company on the basis of ten (10) pre-consolidation common shares for every one (1) post-consolidation common shares, subject to the approval of shareholders at the upcoming meeting of shareholders to t
Nov 30, 2022 07:00 am ET
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation
MONTREAL, Nov. 30, 2022 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that the Company filed with the TSX Venture Exchange ("the "TSX-V") a Notice in respect of a normal course issuer bid (the "NCIB") to be transacted through the facilities of the TSX-V.
Nov 30, 2022 07:00 am ET
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation
MONTREAL, Nov. 30, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that the Company filed with the TSX Venture Exchange ("the "TSX-V") a Notice in respect of a normal course issuer bid (the "NCIB") to be transacted through the facilities of the TSX-V.
Nov 25, 2022 07:00 am ET
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
Company recorded a record high of $12 million in quarterly revenue (84% YoY increase) and Net Income of $2.6 million
Nov 25, 2022 07:00 am ET
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
Company recorded a record high of $12 million in quarterly revenue (84% YoY increase) and Net Income of $2.6 million
Sep 30, 2022 03:46 pm ET
Cannara Releases 14 New SKU's Across Ontario and Quebec
MONTREAL, Sept. 30, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, announced today that it will be releasing 14 new SKU's of its premium-grade cannabis in Ontario and Quebec under the Company's flagship brands, Tribal, Nugz, and Orchid CBD brands.
Sep 30, 2022 03:46 pm ET
Cannara Releases 14 New SKU's Across Ontario and Quebec
MONTREAL, Sept. 30, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, announced today that it will be releasing 14 new SKU's of its premium-grade cannabis in Ontario and Quebec under the Company's flagship brands, Tribal, Nugz, and Orchid CBD brands.
Sep 20, 2022 09:00 am ET
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark
MONTREAL, Sept. 20, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, today announced its entry into the British Columbia (BC) market. In addition, the Company is also pleased to announce the launch of its first two premium product offerings in the vape and accessory categories.
Sep 20, 2022 09:00 am ET
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark
MONTREAL, Sept. 20, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, today announced its entry into the British Columbia (BC) market. In addition, the Company is also pleased to announce the launch of its first two premium product offerings in the vape and accessory categories.
Sep 01, 2022 09:25 am ET
Acquisition of Common Shares of Cannara Biotech Inc.
MONTREAL, Sept. 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, announced that on August 31, 2022, Derek Stern, a director and principle shareholder owning more than 10% of the issued and outstanding common shares ("Common Shares") of Cannara, acquired 720,000 common shares ("Purchased Shares") in the capital of Cannara, representing approximately
Sep 01, 2022 09:25 am ET
Acquisition of Common Shares of Cannara Biotech Inc.
MONTREAL, Sept. 1, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, announced that on August 31, 2022, Derek Stern, a director and principle shareholder owning more than 10% of the issued and outstanding common shares ("Common Shares") of Cannara, acquired 720,000 common shares ("Purchased Shares") in the capital of Cannara, representing approximately
Aug 10, 2022 08:30 am ET
Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022
MONTREAL, Aug. 10, 2022 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Wednesday, August 17th, 2022, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have an oppor
Aug 10, 2022 08:30 am ET
Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022
MONTREAL, Aug. 10, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Wednesday, August 17th, 2022, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have a
Aug 03, 2022 08:30 am ET
Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada
Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products throughout Canada in addition to providing access to direct breeder's knowledge and insights on Exotic Genetix' cannabis strains
Aug 03, 2022 08:30 am ET
Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada
Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products throughout Canada in addition to providing access to direct breeder's knowledge and insights on Exotic Genetix' cannabis strains
Jul 27, 2022 08:00 am ET
Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results
Company recorded a record high of $10.1 million in quarterly revenue and $24.1 million in year-to-date revenue, delivering its fifth consecutive quarter of positive Q3 2022 Adjusted EBITDA of $1.8M with net income of $1.4 million
Jul 27, 2022 08:00 am ET
Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results
Company recorded a record high of $10.1 million in quarterly revenue and $24.1 million in year-to-date revenue, delivering its fifth consecutive quarter of positive Q3 2022 Adjusted EBITDA of $1.8M with net income of $1.4 million
Jun 01, 2022 04:00 pm ET
Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking
MONTREAL, June 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., announced today that it has closed on a $50M credit facility led by BMO Commercial Banking. The credit facility, effective May 31, 2022, includes a three-year term loan for $45 million with an accordion for up to an additional $10 million and a $5 million line of credit. Additional favorable terms attached to t
Jun 01, 2022 04:00 pm ET
Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking
MONTREAL, June 1, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., announced today that it has closed on a $50M credit facility led by BMO Commercial Banking. The credit facility, effective May 31, 2022, includes a three-year term loan for $45 million with an accordion for up to an additional $10 million and a $5 million line of credit. Additional favorable terms attached to t
May 04, 2022 08:30 am ET
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services
MONTREAL, May 4, 2022 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer, Nicholas Sosiak, will be presenting at Canaccord Genuity's 6th Annual Cannabis Conference at 10:30am Eastern on May 11th, 2022. Mr. Sosiak will present the Company's corporate highlights and also provide an update on the company's second quarter financial results.
May 04, 2022 08:30 am ET
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services
MONTREAL, May 4, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer, Nicholas Sosiak, will be presenting at Canaccord Genuity's 6th Annual Cannabis Conference at 10:30am Eastern on May 11th, 2022. Mr. Sosiak will present the Company's corporate highlights and also provide an update on the company's second quarter financial r
Apr 27, 2022 08:00 am ET
Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results
Company recorded $7.4 million in quarterly revenues and delivers fourth consecutive quarter of positive Adjusted EBITDA while continuing to rapidly scale production capacity at the Valleyfield Facility
Apr 27, 2022 08:00 am ET
Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results
Company recorded $7.4 million in quarterly revenues and delivers fourth consecutive quarter of positive Adjusted EBITDA while continuing to rapidly scale production capacity at the Valleyfield Facility
Jan 20, 2022 01:20 pm ET
Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results
Strong execution leads to third consecutive quarter of positive Adjusted EBITDA Company recorded quarterly revenues of $6.6 million Growing operations initiated at new Valleyfield FacilityAll financial results are reported in Canadian dollars, unless otherwise stated.
Jan 18, 2022 07:00 am ET
Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022
Company invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on VirtualInvestorConferences.com
Jan 18, 2022 07:00 am ET
Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022
Company invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on VirtualInvestorConferences.com
Dec 08, 2021 07:00 am ET
Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results
Fiscal 2021 revenues of $17.3 million, gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million, strong indicators of Cannara's performance and successful operating strategy
Dec 08, 2021 07:00 am ET
Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results
Fiscal 2021 revenues of $17.3 million, gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million, strong indicators of Cannara's performance and successful operating strategy
Dec 01, 2021 07:30 am ET
Cannara Biotech Inc. upsizes CIBC Credit Facility to $22 Million
Refinancing will decrease the Company's overall debt servicing costs to 4.3%
Sep 27, 2021 08:00 am ET
Cannara's Valleyfield Facility Receives Processing and Cultivation License
10 000 plants to be propagated in the re-designed Valleyfield zones to replicate indoor growing conditions
Sep 02, 2021 08:00 am ET
Aug 10, 2021 10:15 am ET
TSX Venture Exchange, Cannara Biotech Inc., C-Suite at The Open
TORONTO, Aug. 10, 2021 /CNW/ - Nicholas Sosiak, CFO, Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE), shares his Company's story in an interview with TMX Group.
Jul 28, 2021 08:30 am ET
Cannara Biotech Inc. Reports Strong First Quarterly Profit Driven by Retail Debut
Third quarter revenue of $7.2 million, gross profit of $4.4 million, and net income of $1.7 millionshowcases success of market strategy and operating model
Jul 09, 2021 08:30 am ET
Cannara Biotech Inc. Completes Additional $5 Million Private Placement
MONTREAL, July 9, 2021 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium–grade cannabis and derivative products with two Quebec–based mega cultivation facilities spanning over 1,650,000 sq. ft., today announced that it has closed an additional $5 million private placement at an issue price per share of $0.18, resulting in the issuance of 27,777,778 new common shares in the capital of the Company. This follows the Company's previously-announced acquisition of the one million square foot licensed cultiv
Jun 28, 2021 08:35 am ET
Cannara Biotech Inc. Reports Preliminary Results Ahead of Third Quarter 2021
Preliminary results from first commercial quarter in market show successful market launch in Quebec
Jun 25, 2021 08:35 am ET
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com June 30th at 11:30 ET
MONTREAL, June 25, 2021 /PRNewswire/ -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of premium–grade cannabis products for the Quebec and Canadian markets, today announced that Nicholas Sosiak, Chief Financial Officer of Cannara, will present live at VirtualInvestorConferences.com on June 30th at 11:30 ET.
Jun 23, 2021 07:00 am ET
Cannara Biotech Inc. Completes Acquisition of TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec
Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually
Jun 23, 2021 07:00 am ET
Cannara Biotech Inc. Completes Acquisition of TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec
Newly built fully automated one million sq. ft. facility increases Company's production capacity of premium-grade cannabis up to 125,000 kg annually
Jun 10, 2021 07:00 am ET
Cannara Biotech Enters Into Agreement to Acquire TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec
Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually
Jun 10, 2021 07:00 am ET
Cannara Biotech Enters Into Agreement to Acquire TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec
Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually
Jun 10, 2021 07:00 am ET
The Green Organic Dutchman Signs Sale Agreement and Leaseback for its Quebec Facility
Gross total value of $32.7 million, consisting of sale price of $27 million, plus $5.7 million from Hydro Quebec deposit return TGOD's operations to remain in Valleyfield, through leaseback agreement Sale expected to close on or before June 22, 2021 TGOD to use net proceeds to eliminate senior term debt TORONTO, June 10, 2021 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX: TGOD) (US-OTC: TGODF), a leading producer of premium certified organically grown cannabis, is pleased to announce that its wholly owned Quebec subsidiary Medican Organic Inc. ("Medican") h
Jun 10, 2021 07:00 am ET
The Green Organic Dutchman Signs Sale Agreement and Leaseback for its Quebec Facility
Gross total value of $32.7 million, consisting of sale price of $27 million, plus $5.7 million from Hydro Quebec deposit return TGOD's operations to remain in Valleyfield, through leaseback agreement Sale expected to close on or before June 22, 2021 TGOD to use net proceeds to eliminate senior term debt TORONTO, June 10, 2021 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX: TGOD) (US-OTC: TGODF), a leading producer of premium certified organically grown cannabis, is pleased to announce that its wholly owned Quebec subsidiary Medican Organic Inc. ("Medi
Apr 28, 2021 09:25 am ET
Cannara Biotech Delivers Strong Q2 2021 Results
Significant second quarter revenue generation of $1.2 million and gross profit increase to $2.1 million showcases Cannara's positive trajectory
Apr 12, 2021 05:30 pm ET
Cannara Virtually Closes The Market
TORONTO, April 12, 2021 /CNW/ - Nicholas Sosiak, Chief Financial Officer, Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) and his team joined Berk Sumen, Head, Company Services, TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and close the market.
Apr 07, 2021 04:00 pm ET
Cannara Biotech Commences Trading on TSXV on April 8, 2021
TSXV market listing anticipated to improve visibility of Cannara among the investor community
Mar 11, 2021 08:00 am ET
Cannara Biotech Secures Conditional Approval to List on the TSX Exchange
Anticipated TSXV market listing coincides with the appointment of Nicholas Sosiak to CFO and retail market debut
Feb 25, 2021 08:28 am ET
Cannara Biotech Launches Cannabis Brand Portfolio Now Available in Quebec - Tribal, Nugz, Orchid CBD
Cannara's three new brands – Tribal, Nugz and Orchid CBD
Jan 29, 2021 03:04 pm ET
Cannara Biotech Inc. Reports Q1 2021 Financial Results
- Expects to generate revenue from letter of intent with the Société québécoise du cannabis by end of February or early March 2021 -
Jan 08, 2021 07:52 am ET
IIROC Trade Resumption - LOVE
VANCOUVER, BC, Jan. 8, 2021 /CNW/ - Trading resumes in:
Jan 08, 2021 06:27 am ET
Cannara Biotech Receives Sales Licence from Health Canada
Cannara to start delivering cannabis products to the Société québécoise du cannabis (SQDC) under its existing Letter of Intent.
Jan 08, 2021 06:27 am ET
Cannara Biotech Receives Sales Licence from Health Canada
Cannara to start delivering cannabis products to the Société québécoise du cannabis (SQDC) under its existing Letter of Intent.
Jan 07, 2021 10:30 am ET
IIROC Trading Halt - LOVE
VANCOUVER, BC, Jan. 7, 2021 /CNW/ - The following issues have been halted by IIROC:
Dec 15, 2020 06:02 pm ET
Cannara Biotech Inc. (CSE: LOVE) announces Year-End and Q4 2020 Results
- Cannabis Cultivation at Farnham, one of Canada's largest indoor facilities, dialed in and operational-
Dec 15, 2020 06:02 pm ET
Cannara Biotech Inc. (CSE: LOVE) announces Year-End and Q4 2020 Results
- Cannabis Cultivation at Farnham, one of Canada's largest indoor facilities, dialed in and operational-
Nov 05, 2020 03:30 pm ET
Cannara Biotech Inc. Appoints Donald Olds to Board of Directors
MONTREAL, Nov. 5, 2020 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) today announced the appointment of Donald Olds as a Director on the Company's board of directors.
Jul 27, 2020 07:30 am ET
Cannara Biotech Inc. Reports Q3 2020 Financial Results
MONTREAL, July 27, 2020 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF), (FRA: 8CB), today announced financial results for the three and nine-month periods ended May 31, 2020. Unless otherwise noted, all dollar amounts are expressed in Canadian dollars.
Jul 07, 2020 05:00 pm ET
Cannara Completes Acquisition of Global shopCBD.com
MONTREAL, July 7, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) announced today it has closed on its previously announced offer to acquire all of the issued and outstanding shares of Global shopCBD.com Inc. ("Global") not already owned by Cannara (the "Transaction").
Jul 06, 2020 07:30 am ET
Cannara enters LOI with SQDC for Entire First Year Production
- Operations Accelerating with 100th Quebec Employee Hired -
May 27, 2020 07:30 am ET
Cannara Proposes Agreement to Acquire Global shopCBD.com
VANCOUVER, May 27, 2020 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis derivative products, is pleased to announce that it has entered into a proposed share exchange agreement dated May 26, 2020 among the Company, Global shopCBD.com Inc. ("Global") and the shareholders of Global (the "Exchange Agreement"), pursuant to which, the Company will acquire all of the issued and outstanding shares of Glob
May 27, 2020 07:30 am ET
Cannara Proposes Agreement to Acquire Global shopCBD.com
VANCOUVER, May 27, 2020 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis derivative products, is pleased to announce that it has entered into a proposed share exchange agreement dated May 26, 2020 among the Company, Global shopCBD.com Inc. ("Global") and the shareholders of Global (the "Exchange Agreement"), pursuant to which, the Company will acquire all of the issued and outstanding shares of Glob
May 15, 2020 05:00 pm ET
Cannara Biotech Inc. appoints Mary Durocher as New Board Director
VANCOUVER, May 15, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, today announced the appointment of Mary Durocher as a Director on Cannara's Board, effective immediately. Ms. Durocher is President and Chief Consultant of Fox D Consulting.
May 15, 2020 05:00 pm ET
Cannara Biotech Inc. appoints Mary Durocher as New Board Director
VANCOUVER, May 15, 2020 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, today announced the appointment of Mary Durocher as a Director on Cannara's Board, effective immediately. Ms. Durocher is President and Chief Consultant of Fox D Consulting.
May 14, 2020 05:12 pm ET
FSD Pharma Reports First Quarter 2020 Financial Results
Provides Business Update
Apr 20, 2020 07:30 am ET
Cannara Harvests First Crop on 420
300 kgs of Carefully Crafted Premium Indoor Cannabis Marks Pivotal Milestone
Apr 20, 2020 07:30 am ET
Cannara Harvests First Crop on 420
300 kgs of Carefully Crafted Premium Indoor Cannabis Marks Pivotal Milestone
Apr 16, 2020 05:00 pm ET
Cannara Biotech Inc. Reports Q2 2020 Financial Results
Company well-financed with ample resources to reach commercial milestones in H2 2020
Apr 16, 2020 05:00 pm ET
Cannara Biotech Inc. Reports Q2 2020 Financial Results
Company well-financed with ample resources to reach commercial milestones in H2 2020
Feb 20, 2020 01:30 am ET
Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma's Position in Cannara
Insiders' increase stake in Cannara coincides as cultivation poised to commence
Feb 06, 2020 09:45 am ET
Lennie Ryer and Barry Laxer of Cannara Biotech Inc. are Featured On The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 6, 2020) - The Stock Day Podcast welcomed Cannara Biotech Inc. (OTCQB: LOVFF) ("the Company"), a company building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Québec. Lennie Ryer and Barry Laxer joined Stock Day host Everett Jolly.
Feb 03, 2020 07:53 am ET
IIROC Trade Resumption - LOVE
VANCOUVER, Feb. 3, 2020 /CNW/ - Trading resumes in:
Jan 31, 2020 04:00 pm ET
Cannara Biotech's Farnham Facility Receives Cultivation Licence
VANCOUVER, Jan. 31, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and medical sale of premium dried cannabis and cannabis derivatives under The Cannabis Act, today announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham Facility, in Québec.
Jan 31, 2020 02:59 pm ET
IIROC Trading Halt - LOVE
VANCOUVER, Jan. 31, 2020 /CNW/ - The following issues have been halted by IIROC:
Jan 20, 2020 06:30 am ET
Cannara Biotech Reports Q1 2020 Financial Results
VANCOUVER, Jan. 20, 2020 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-infused products, today announced financial results for the three-month period ended November 30, 2019. Unless otherwise noted, all dollar amounts are expressed in Canadian dollars.
Nov 26, 2019 03:30 pm ET
Cannara Biotech Reports Q4 and Year-End 2019 Financial Results
VANCOUVER, Nov. 26, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium cannabis and cannabis-infused products, today announced financial results for the three month period and year ended August 31, 2019. Unless otherwise noted, all dollar amounts are expressed in Canadian dollars.
Oct 10, 2019 07:30 am ET
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
VANCOUVER, Oct. 10, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial Bank of Commerce. These funds will reduce the existing vendor take-back mortgage, thereby significantly reducing debt service costs.
Oct 10, 2019 07:30 am ET
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
VANCOUVER, Oct. 10, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial Bank of Commerce. These funds will reduce the existing vendor take-back mortgage, thereby significantly reducing debt service costs.
Sep 12, 2019 01:30 pm ET
IIROC Trade Resumption - LOVE
VANCOUVER, Sept. 12, 2019 /CNW/ - Trading resumes in:
Sep 12, 2019 01:15 pm ET
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
VANCOUVER, Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec. The submission is the final step required to obtain a license to cultivate and process cannabis at the facility.
Sep 12, 2019 01:15 pm ET
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
VANCOUVER, Sept. 12, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec. The submission is the final step required to obtain a license to cultivate and process cannabis at the facility.
Sep 12, 2019 12:59 pm ET
IIROC Trading Halt - LOVE
VANCOUVER, Sept. 12, 2019 /CNW/ - The following issues have been halted by IIROC:
Aug 15, 2019 04:34 pm ET
Cannara Announces Appointment of New Chief Operating Officer
VANCOUVER, Aug. 15, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. Barry is a successful business leader that brings over 25 years of experience of leading large-scale operations both domestically and internationally.
Aug 15, 2019 04:34 pm ET
Cannara Announces Appointment of New Chief Operating Officer
VANCOUVER, Aug. 15, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. Barry is a successful business leader that brings over 25 years of experience of leading large-scale operations both domestically and internationally.
Aug 05, 2019 08:35 am ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Aug 05, 2019 08:35 am ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the August 1, 2019 OTCQB Venture Company Conference are now available for on-demand viewing at VirtualInvestorConferences.com.
Jul 31, 2019 08:35 am ET
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1
VANCOUVER, British Columbia, July 31, 2019 /PRNewswire/ -- Cannara Biotech (OTCQB:LOVFF) (CSE: LOVE), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech's Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1.
Jul 30, 2019 08:35 am ET
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1
VANCOUVER, British Columbia, July 30, 2019 /PRNewswire/ -- Cannara Biotech (OTCQB: LOVFF) (CSE: LOVE), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech's Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1.
Jul 30, 2019 08:35 am ET
Live OTCQB Venture Company Investor Conference August 1st
Company executives will share vision and answer audience questions at VirtualInvestorConferences.com
Jul 30, 2019 08:35 am ET
Live OTCQB Venture Company Investor Conference August 1st
NEW YORK, July 30, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET, with the first live webcast at 9:30 AM ET, on Thursday, August 1st.
Jul 25, 2019 07:30 am ET
Cannara Biotech Inc. Reports Q3 2019 Results
VANCOUVER, July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019.
Jul 25, 2019 07:30 am ET
Cannara Biotech Inc. Reports Q3 2019 Results
VANCOUVER, July 25, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019.
Jul 12, 2019 07:30 am ET
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
VANCOUVER, July 12, 2019 /CNW/ - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares of the Corporation (each a "Common Share" and collectively, the "Common Shares") at a price of $0.18 per Common Share (the "Offering"). The net proceeds from the Offering shall be used for general corporate purposes including the ongoing build-out at Ca
Jul 12, 2019 07:30 am ET
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
VANCOUVER, July 12, 2019 /PRNewswire/ - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares of the Corporation (each a "Common Share" and collectively, the "Common Shares") at a price of $0.18 per Common Share (the "Offering"). The net proceeds from the Offering shall be used for general corporate purposes including the ongoing build-ou
Jul 03, 2019 05:00 pm ET
Horizons ETFs Rebalances Marijuana-Focused ETFs
TORONTO, July 3, 2019 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ":TSX), the Horizons US Marijuana Index ETF ("HMUS":NEO) and the Horizons Emerging Marijuana Growers Index ETF ("HMJR":NEO).
May 24, 2019 07:30 am ET
Cannara Biotech Appoints Dr. Sara May to its Board of Directors
VANCOUVER, May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the Company's Board of Directors, effective immediately. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the Company's Board.
May 24, 2019 07:30 am ET
Cannara Biotech Appoints Dr. Sara May to its Board of Directors
VANCOUVER, May 24, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the Company's Board of Directors, effective immediately. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the Company's Board.
May 15, 2019 07:30 am ET
Cannara Biotech Commences Trading on the OTCQB Market in the United States
VANCOUVER, May 15, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the trading symbol "CNBTF".
May 15, 2019 07:30 am ET
Cannara Biotech Commences Trading on the OTCQB Market in the United States
VANCOUVER, May 15, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the trading symbol "CNBTF".
Apr 30, 2019 10:04 am ET
PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES
Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has entered into a Reseller Agreement with Shopcbd.com, a subsidiary of Cannara Biotech, Inc. (CSE: "LOVE")...
Apr 29, 2019 07:30 am ET
Cannara Biotech Reports Q2 2019 Results
VANCOUVER, April 29, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended February 28, 2019.
Apr 29, 2019 07:30 am ET
Cannara Biotech Reports Q2 2019 Results
VANCOUVER, April 29, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended February 28, 2019.
Apr 08, 2019 07:30 am ET
Cannara Biotech Appoints Jack Kay as New Board Director
MONTREAL, April 8, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex.
Apr 08, 2019 07:30 am ET
Cannara Biotech Appoints Jack Kay as New Board Director
MONTREAL, April 8, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex.
Mar 28, 2019 10:00 am ET
The CBD Wave is Coming: How Companies are Prepared to Meet Market Demand
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the rise of CBD within the overall cannabis market in the US and internationally, and how companies are preparing to deal with...
Mar 26, 2019 07:30 am ET
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform
MONTREAL, March 26, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the "Offering"). Cannara remains the majority shareholder of the U.S. based online e-commerce platform with an approximately 61% ownership position.
Mar 26, 2019 07:30 am ET
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform
MONTREAL, March 26, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the "Offering"). Cannara remains the majority shareholder of the U.S. based online e-commerce platform with an approximately 61% ownership position.
Mar 18, 2019 04:14 pm ET
Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF
Quarterly rebalance includes a leading U.S.-based CBD producer
Mar 14, 2019 07:30 am ET
Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update
MONTREAL, March 14, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara's Farnham, in process with Health Canada, has been modified accordingly. The 40 000-square-foot expansion will provide more flexibility for cultivation and post-harvest operations. The timelines to complete Phase 1 constr
Mar 14, 2019 07:30 am ET
Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update
MONTREAL, March 14, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara's Farnham, in process with Health Canada, has been modified accordingly. The 40 000-square-foot expansion will provide more flexibility for cultivation and post-harvest operations. The timelines to complete Phase 1
Feb 21, 2019 09:00 am ET
4 Companies Shaping The CBD-Infused Beverage Industry
With the global CBD movement supercharged by the 2018 U.S. Farm Bill, cannabis and beverage companies alike are officially beginning to launch CBD-infused beverage products in the U.S. market.The rollout of various CBD-infused beverages throughout...
Feb 11, 2019 06:30 am ET
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
MONTRÉAL, Feb. 11, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Company's common shares continue to be listed on the Canadian Securities Exchange under the trading symbol "LOVE".
Feb 11, 2019 06:30 am ET
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
MONTRÉAL, Feb. 11, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Company's common shares continue to be listed on the Canadian Securities Exchange under the trading symbol "LOVE".
Feb 07, 2019 06:30 am ET
Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category
Partners with a Leading Quebec Microbrewery
Feb 07, 2019 06:30 am ET
Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category
Partners with a Leading Quebec Microbrewery
Jan 29, 2019 06:30 am ET
Cannara Biotech Reports First Quarter Results
MONTRÉAL, Jan. 29, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018.
Jan 29, 2019 06:30 am ET
Cannara Biotech Reports First Quarter Results
MONTRÉAL, Jan. 29, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018.
Jan 24, 2019 06:30 am ET
Cannara Biotech to Enter the U.S. Hemp-CBD Market, Launching an Online E-Commerce Platform - shopCBD.com
- shopCBD.com a one-stop shop for all CBD products -
Jan 24, 2019 06:30 am ET
Cannara Biotech to Enter the U.S. Hemp-CBD Market, Launching an Online E-Commerce Platform - shopCBD.com
- shopCBD.com a one-stop shop for all CBD products -
Jan 15, 2019 09:10 am ET
CSE New Listing - Cannara Biotech Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2019) - Cannara Biotech (CSE:LOVE) is one of the latest new listings on the Canadian Securities Exchange. In June 2018, Cannara completed the acquisition of a 625,000 sq. ft. indoor facility in Farnham, Quebec, located 45 minutes from downtown Montreal.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
